Fudge James Mack, Page Bernie, Mackrell Amy, Lee Inhyung
Hill Country Animal League, Boerne, TX, USA.
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
J Feline Med Surg. 2020 Feb;22(2):91-99. doi: 10.1177/1098612X19826700. Epub 2019 Feb 5.
This study sought to determine if bupivacaine targeted at specific, potentially painful sites could enhance postoperative analgesia in routine feline ovariohysterectomies. A secondary objective was to assess the utility of multiple acute pain scales for cats in a high-volume surgery setting.
Two hundred and twelve cats were included in a prospective, randomized, double-blinded, placebo-controlled clinical trial. Anesthesia included buprenorphine, ketamine, dexmedetomidine and isoflurane. A ventral midline ovariohysterectomy was performed and cats were administered bupivacaine (2 mg/kg), placebo control (0.9% saline) or sham control (observation only) intraoperatively at the ovarian suspensory ligaments and vessels, uterine body and incisional subcutaneous tissues. Two pain scales were used to assess cats postoperatively. Initially, a multidimensional composite pain scale (MCPS) and a 0-10 numeric pain rating scale (NRS) were used. Subsequently, the MCPS was replaced with a modified Colorado State University Feline Acute Pain Scale (mCSU). Pain scores for the test groups were compared using a one-way ANOVA and a Holm-Bonferroni post hoc analysis when a difference was found ( <0.05).
Pain for the bupivacaine group was lower than the control groups at 1 h post-recovery and discharge, attaining significance with higher body weights. The values were 0.008 and 0.004 for 1 h post-recovery and discharge, respectively. Pain scores between evaluators for the MCPS and NRS correlated poorly with values for 1 h post-recovery and discharge of -0.08 and 0.22, respectively. Additionally, the MCPS proved difficult to use and time consuming, especially for feral and fractious patients, and was replaced with the mCSU.
Targeted bupivacaine reduced early postoperative pain scores following routine feline ovariohysterectomies. The technique used was simple, requiring just over a minute to perform at minimal additional cost. The MCPS was not ideal for use in a high-volume spay setting.
本研究旨在确定在常规猫卵巢子宫切除术中,将布比卡因注射到特定的、可能引起疼痛的部位是否能增强术后镇痛效果。第二个目的是评估在高容量手术环境中多种急性疼痛量表对猫的实用性。
212只猫被纳入一项前瞻性、随机、双盲、安慰剂对照临床试验。麻醉用药包括丁丙诺啡、氯胺酮、右美托咪定和异氟烷。实施腹中线卵巢子宫切除术,术中在卵巢悬韧带和血管、子宫体及切口皮下组织给猫注射布比卡因(2mg/kg)、安慰剂对照(0.9%生理盐水)或假对照(仅观察)。术后使用两种疼痛量表评估猫的情况。最初,使用多维综合疼痛量表(MCPS)和0至10数字疼痛评分量表(NRS)。随后,MCPS被改良的科罗拉多州立大学猫急性疼痛量表(mCSU)取代。当发现差异时(<0.05),使用单因素方差分析和Holm-Bonferroni事后分析比较试验组的疼痛评分。
布比卡因组在恢复和出院后1小时的疼痛程度低于对照组,体重较大时差异具有显著性。恢复后1小时和出院后1小时的P值分别为0.008和0.004。MCPS和NRS评估者之间的疼痛评分与恢复后1小时和出院后1小时的P值相关性较差,分别为-0.08和0.22。此外,事实证明MCPS使用困难且耗时,尤其是对于野生和暴躁的猫,因此被mCSU取代。
在常规猫卵巢子宫切除术后,靶向注射布比卡因可降低早期术后疼痛评分。所采用的技术简单,只需一分钟多一点即可完成,成本增加极少。MCPS在高容量绝育手术环境中并不理想。